Pronova’s Phase III heart failure study meets endpoint
The GISSI- heart failure (HF) trial was designed and conducted by the Gruppo Italiano Studio Sopravvivenza Insufficienzia Cardiaca (GISSI) in Italy to investigate the clinical effects of a
Rocket Pharmaceuticals has entered into a credit facility agreement of up to $150m with Hercules Capital to support the ongoing development of its cardiovascular portfolio.
The acquisition includes MediSolution’s healthcare-specific product suites including the electronic health record systems, a patient management suite, clinical department systems, lab information systems, and public health and community